AI Boosts Efficacy of Cancer Treatments but Doctors Remain Key 🔗 “While #AI offers insights based on complex data, the human touch remains crucial in cancer care,” said Issam El Naqa, PhD, chair of the Machine Learning Dept. at Moffitt. #RadOncNews

Help Us Swim by @StephDudzinski 🔗 "Radiation oncology has often endearingly been called “the best-kept secret in medicine,” but this common statement may actually be a disservice to our field."

A Rare Case of Skull Base Phosphaturic Mesenchymal Tumor 🔗 A 55-year-old woman presented with a history of multiple bone fractures, headache, double vision, left-ear impaired hearing, and impaired urinary control. #RadOnc #RadOncEd #MedEd #CaseStudy

A Rare Case of Mycosis Fungoides of the Scalp Treated With Electron-Beam Radiation Therapy 🔗 #RadOnc #RadOncEd #CaseStudy

Gastric Fistula After MR-Guided Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma 🔗 #RadOnc #RadOncEd #CaseStudy

@Lunit_AI Enhances Precision in Predicting Outcomes for mCRC Patients Undergoing HER2-Targeted Therapy 🔗 "This study underscores the potential of #AI technology to redefine how we evaluate biomarkers and predict treatment responses," #RadOnc

Case Report: Strip alopecia in high-dose VMAT-based stereotactic radiosurgery 🔗 #RadOnc #RadOncEd

Inherited Gene Elevates Prostate Cancer Risk 🔗 “Inherited risk of #prostatecancer is roughly twice that of breast cancer, but its genetic complexity is also considerably greater; this has been a formidable obstacle for global studies,” #RadOncNews

RT @ASTRO_org: ASTRO is accepting nominations for the 2025 ASTRO Mentorship Award. Nominations must be submitted by a colleague or mentee a…

@SNM_MI Launches Thyroid Cancer Registry 🔗 “The thyroid cancer registry, and RaPTR as a whole, represents a rich resource for clinical investigation and educational opportunities,” said Orhan K Oz, MD, PhD #RadOnc #RadOncNews #ThyroidCancer

Asymptomatic Brain Metastasis Common in Stage 4 Breast Cancer Patients 🔗 “Our study suggests that asymptomatic brain metastasis is quite common in stage 4 breast cancer,” said Kamran Ahmed, MD #RadOnc #RadOncNews #BreastCancer

February is #NationalCancerPreventionMonth ! In recognition of this we are going to be sharing articles discussing different kinds of cancer prevention

Research Uncovers How Tumor Cells Die After Radiotherapy 🔗 “To the cell, these repair byproducts look like a viral or bacterial infection. This causes the cancer cell to die in a manner that alerts the immune system. Which is what we do want.” #RadOnc

Personalizing Approaches to Patient Education Throughout the Radiation Oncology Workflow 🔗 #RadOnc

Our aim is to describe extracapsular prostate brachytherapy (ECPB) techniques using low-dose-rate (LDR) for patients with intermediate-risk prostate cancer (IRPC) and selected high-risk prostate cancer (HRPC). 🔗 #RadOnc #RadOncEd #MedEd #ProstateCancer

Want to hear more from @JillGunther MD, PhD, associate professor of radiation oncology at @MDAndersonNews ? 🔗 #RadOnc #RadiationOncology

New Practice Guidelines Issued for FAP PET 🔗 “FAP PET imaging can be used for initial staging, re-staging, therapy response evaluation, and whole-body target expression assessment for therapy selection,” noted the authors. #RadOnc #RadOncNews

Planning Target Volume Margin Assessment of Retroperitoneal Tumors Using Robotic SBRT With Spine Tracking 🔗 #RadOnc #OligometastaticDisease #RadOncEd

📢 FREE Webinar opportunity with @Radformation A Close Look at Radiation Oncology Billing Practices: Insights and Data from QuickCode’s Pilot Program 🔗🎓 #RadOncEd #MedEd

🔗 Several fractionation and planning protocols exist with CHHiP and PROFIT (60 Gy in 20 fractions) being 2 of the most commonly used. We retrospectively compared the doses received by organs at risk (OARs) using these 2 protocols #RadOnc #ProstateCancer